Andy Chevigné

2.3k citations

76 papers · 1.5k indexed · h-index 24

Impact in

Immunology top 5%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Oncology top 5%
- Chemokine receptors and signaling

Papers in ⓘ

Immunology 33
- Immunotherapy and Immune Responses 19
- T-cell and B-cell Immunology 14
Oncology 42
- Chemokine receptors and signaling 41

Co-authors: Martyna Szpakowska (51 shared papers)Max Meyrath (19 shared papers)Jean-Claude Schmit (5 shared papers)Julien Hanson (8 shared papers)Moreno Galleni (12 shared papers)Virginie Fiévez (4 shared papers)Brian F. Volkman (6 shared papers)Andrew B. Kleist (3 shared papers)
Journals: Biochemical Pharmacology (6 papers)Frontiers in Immunology (5 papers)Journal of Leukocyte Biology (4 papers)Nature Communications (4 papers)International Journal of Molecular Sciences (4 papers)
Partner nations: Luxembourg Belgium Germany

In The Last Decade

Andy Chevigné

74 papers receiving 1.5k citations

Peers

Countries citing papers authored by Andy Chevigné

Since Specialization

Citations

This map shows the geographic impact of Andy Chevigné's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Chevigné with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Chevigné more than expected).

Fields of papers citing papers by Andy Chevigné

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Chevigné. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Chevigné. The network helps show where Andy Chevigné may publish in the future.

Co-authors

The 25 scholars most cited alongside Andy Chevigné, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andy Chevigné Line = papers co-authored together Andy Chevigné links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model Biochemical Pharmacology ·Andrew B. Kleist, Anthony E. Getschman, Joshua J. Ziarek, Amanda M. Nevins, Pierre‐Arnaud Gauthier, Andy Chevigné, Martyna Szpakowska, Brian F. Volkman	2016	92
2	A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Clinical Cancer Research ·Elin Sjöberg, Max Meyrath, Laura Milde, Mercedes Herrera, John Lövrot, Daniel Hägerstrand, Oliver Frings, Margarita Bartish, Charlotte Rolny, Erik L. L. Sonnhammer, Andy Chevigné, Martin Augsten, Arne Östman	2019	87
3	The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides Nature Communications ·Max Meyrath, Martyna Szpakowska, Julian Zeiner, Laurent Massotte, Myriam P. Merz, Tobias Benkel, Katharina Simon, Jochen Ohnmacht, Jonathan D. Turner, Rejko Krüger, Vincent Seutin, Markus Ollert, Evi Kostenis, Andy Chevigné	2020	82
4	The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment Cells ·Nathan Reynders, Dayana Abboud, Alessandra Baragli, Muhammad Zaeem Noman, Bernard Rogister, Simone P. Niclou, Nikolaus Heveker, Bassam Janji, Julien Hanson, Martyna Szpakowska, Andy Chevigné	2019	74
5	Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors Biochemical Pharmacology ·Martyna Szpakowska, Virginie Fiévez, Karthik Arumugan, Nico van Nuland, Jean-Claude Schmit, Andy Chevigné	2012	71
6	Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds ACS Pharmacology & Translational Science ·Elise Wouters, Jolien Walraed, Michael J. Robertson, Max Meyrath, Martyna Szpakowska, Andy Chevigné, Georgios Skiniotis, Christophe P. Stove	2019	49
7	Different contributions of chemokine N‐terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3 British Journal of Pharmacology ·Martyna Szpakowska, Amanda M. Nevins, Max Meyrath, David Rhainds, Thomas D’huys, François Guité‐Vinet, Nadine Dupuis, Pierre‐Arnaud Gauthier, Manuel Counson, Andrew B. Kleist, Geneviève St‐Onge, Julien Hanson, Dominique Schols, Brian F. Volkman, Nikolaus Heveker, Andy Chevigné	2017	49
8	β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the same GPCR in living cells Nature Communications ·Raphael S. Haider, Edda S. F. Matthees, Julia Drube, Mona Reichel, Ulrike Zabel, Asuka Inoue, Andy Chevigné, Cornelius Krasel, Xavier Deupí, Carsten Hoffmann	2022	44
9	New Integrative Method To Generate Bacillus subtilis Recombinant Strains Free of Selection Markers Applied and Environmental Microbiology ·Alain Brans, Patrice Filée, Andy Chevigné, Aurore Claessens, Bernard Joris	2004	39
10	Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7 Biochemical Pharmacology ·Martyna Szpakowska, Nadine Dupuis, Alessandra Baragli, Manuel Counson, Julien Hanson, Jacques Piette, Andy Chevigné	2016	34
11	GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11 Nature Communications ·Dayana Abboud, Adrian Daly, Nadine Dupuis, Mohamed Ali Bahri, Asuka Inoue, Andy Chevigné, Fabien Ectors, Alain Plenevaux, Bernard Pirotte, Albert Beckers, Julien Hanson	2020	33
12	CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6 Cancers ·Andy Chevigné, Bassam Janji, Max Meyrath, Nathan Reynders, Giulia D’Uonnolo, Tomasz Uchański, Malina Xiao, Guy Berchem, Markus Ollert, Yong‐Jun Kwon, Muhammad Zaeem Noman, Martyna Szpakowska	2021	33
13	Orchestration of an Uncommon Maturation Cascade of the House Dust Mite Protease Allergen Quartet Frontiers in Immunology ·Marie-Eve Dumez, Julie Herman, Vincenzo Campizi, Moreno Galleni, Alain Jacquet, Andy Chevigné	2014	32
14	Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists Biochemical Pharmacology ·Martyna Szpakowska, Max Meyrath, Nathan Reynders, Manuel Counson, Julien Hanson, Jan Steyaert, Andy Chevigné	2018	28
15	Der p 1 is the primary activator of Der p 3, Der p 6 and Der p 9 the proteolytic allergens produced by the house dust mite Dermatophagoides pteronyssinus Biochimica et Biophysica Acta (BBA) - General Subjects ·Julie Herman, Nicolas Thelen, Nicolas Smargiasso, Anne Catherine Mailleux, André Luxen, Marie Cloes, Edwin De Pauw, Andy Chevigné, Moreno Galleni, Marie-Eve Dumez	2013	28
16	The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy Advances in cancer research ·Elin Sjöberg, Max Meyrath, Andy Chevigné, Arne Östman, Martin Augsten, Martyna Szpakowska	2020	27
17	vCCL2/vMIP-II, the viral master KEYmokine Journal of Leukocyte Biology ·Martyna Szpakowska, Andy Chevigné	2015	27
18	Activation of the Orphan G Protein–Coupled Receptor GPR27 by Surrogate Ligands Promotes β-Arrestin 2 Recruitment Molecular Pharmacology ·Nadine Dupuis, Céline Laschet, Delphine Franssen, Martyna Szpakowska, Julie Gilissen, Pierre Geubelle, Arvind Soni, Anne‐Simone Parent, Bernard Pirotte, Andy Chevigné, Jean‐Claude Twizere, Julien Hanson	2017	26
19	Allosteric inhibition of VIM metallo-β-lactamases by a camelid nanobody Biochemical Journal ·Jean Sohier, Clémentine Laurent, Andy Chevigné, Els Pardon, Vasundara Srinivasan, U. Wernery, Patricia Lassaux, Jan Steyaert, Moreno Galleni	2013	26
20	Proadrenomedullin N-Terminal 20 Peptides (PAMPs) Are Agonists of the Chemokine Scavenger Receptor ACKR3/CXCR7 ACS Pharmacology & Translational Science ·Max Meyrath, Christie B. Palmer, Nathan Reynders, Alain Vanderplasschen, Markus Ollert, Michel Bouvier, Martyna Szpakowska, Andy Chevigné	2021	26

About Andy Chevigné

Andy Chevigné is a scholar working on Immunology, Oncology, Immunology and Allergy, Virology and Molecular Biology, having authored 76 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (41 papers), Receptor Mechanisms and Signaling (24 papers), Immunotherapy and Immune Responses (19 papers), T-cell and B-cell Immunology (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Allergic Rhinitis and Sensitization (8 papers), Neuropeptides and Animal Physiology (8 papers) and Food Allergy and Anaphylaxis Research (8 papers). The work is most often cited by research in Immunology (581 citations), Oncology (668 citations), Immunology and Allergy (148 citations), Cellular and Molecular Neuroscience (210 citations) and Virology (47 citations). Andy Chevigné has collaborated with scholars based in Luxembourg, Belgium and Germany. Frequent co-authors include Martyna Szpakowska, Max Meyrath, Jean-Claude Schmit, Julien Hanson, Moreno Galleni, Virginie Fiévez, Brian F. Volkman, Andrew B. Kleist, Alain Jacquet and Nadine Dupuis. Their work appears in journals such as Biochemical Pharmacology, Frontiers in Immunology, Journal of Leukocyte Biology, Nature Communications and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact